A second class consisted of carrier proteins such as apolipoprotein M (APOM), apolipoprotein C1 (APOC1), and clusterin (CLU), which play important roles in cholesterol metabolism and are likely to be associated with cirrhosis‐related dyslipidemia due to reduced liver biosynthesis capacity (Chrostek et al, 2014). Here, CLU is linked to metabolic syndrome.